Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/46086
Title: Single cell-derived clones from human adipose stem cells present different immunomodulatory properties
Authors: Sempere, J. M.
Martinez-Peinado, P.
Arribas, M. I.
Reig, J. A.
De La Sen, M. L.
Zubcoff, J. J.
Fraga, M. F.
Fernández, A. F.
Santana, A. 
Roche, E.
UNESCO Clasification: 32 Ciencias médicas
2412 Inmunología
Keywords: Adult stem cells
Cell cloning
Cytokine secretion
DNA-methylation
Inflammation
Issue Date: 2014
Journal: Clinical and experimental immunology (Print) 
Abstract: Human adipose mesenchymal stem cells are a heterogeneous population, where cell cultures derived from single‐cell‐expanded clones present varying degrees of differential plasticity. This work focuses on the immunomodulatory/anti‐inflammatory properties of these cells. To this end, five single‐cell clones were isolated (generally called 1.X and 3.X) from two volunteers. Regarding the expression level of the lineage‐characteristic surface antigens, clones 1·10 and 1·22 expressed the lowest amounts, while clones 3·10 and 3·5 expressed more CD105 than the rest and clone 1·7 expressed higher amounts of CD73 and CD44. Regarding cytokine secretion, all clones were capable of spontaneously releasing high levels of interleukin (IL)‐6 and low to moderate levels of IL‐8. These differences can be explained in part by the distinct methylation profile exhibited by the clones. Furthermore, and after lipopolysaccharide stimulation, clone 3.X produced the highest amounts of proinflammatory cytokines such as IL‐1β, while clones 1·10 and 1·22 highly expressed IL‐4 and IL‐5. In co‐culture experiments, clones 1.X are, together, more potent inhibitors than clones 3.X for proliferation of total, CD3+T, CD4+T and CD8+T lymphocytes and natural killer (NK) cells. The results of this work indicate that the adipose stem cell population is heterogeneous in cytokine production profile, and that isolation, characterization and selection of the appropriate cell clone is a more exact method for the possible treatment of different patients or pathologies.
URI: http://hdl.handle.net/10553/46086
ISSN: 0009-9104
DOI: 10.1111/cei.12270
Source: Clinical and Experimental Immunology [ISSN 0009-9104],v. 176, p. 255-265
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

15
checked on Jul 25, 2021

Page view(s)

8
checked on Jul 24, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.